Medical Technology

@xconomy.com 3 years ago

Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally

@xconomy.com 4 years ago

Five Years After Y Combinator First Admits Biotechs, They’re Dug In

@xconomy.com 4 years ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@xconomy.com 5 years ago

Censinet Takes Off With $7.8M to Track Cyber Risks in Healthcare

@xconomy.com 5 years ago

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

@xconomy.com 5 years ago

To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango

@xconomy.com 5 years ago

Andreessen Leads $300M Bet on Devoted Health’s Senior Care Approach

@xconomy.com 5 years ago

Circulation CEO Talks Sale to LogistiCare & Amazon’s Healthcare Play

@xconomy.com 5 years ago

With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?

@xconomy.com 5 years ago

Boston Scientific Continues M&A Streak with $202M Deal for Cryterion

@xconomy.com 6 years ago

Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M